Search research articles
Contact Us
Filters
Showing results (101-110 of 675) with videos related to
Page
of 68
Sort By:
Journal of Medicinal Chemistry
|
September 24, 2015
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation
Isolda Romero-Canelón, Magdalena Mos, Peter J Sadler
Biochemical Society Transactions
|
October 1, 1980
31P nuclear-magnetic-resonance studies at 24 and 162 MHz of blood containing an anti-arthritic gold phosphine: relaxation via chemical-shift anisotropy
N A Malik, G Otiko, P J Sadler
FEBS Letters
|
October 15, 1978
113Cd nuclear magnetic resonance of metallothionein: non-equivalent CdS4 sites
P J Sadler, A Bakka, P J Beynon
Science (New York, N.Y.)
|
December 9, 1983
Equatorial undercurrent disappears during 1982-1983 el nino
E Firing, R Lukas, J Sadler, et al.
Journal of Applied Toxicology : JAT
|
November 24, 2006
Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells
D Pugazhendhi, A J Sadler, P D Darbre
Journal of Medicinal Chemistry
|
February 2, 2013
The contrasting activity of iodido versus chlorido ruthenium and osmium arene azo- and imino-pyridine anticancer complexes: control of cell selectivity, cross-resistance, p53 dependence, and apoptosis pathway
Isolda Romero-Canelón, Luca Salassa, Peter J Sadler
Chemical & Biomedical Imaging
|
March 27, 2026
A Correlative X‑ray Bioimaging Triad for Metals in Biomedical Research
Rafael C Marchi, Maria Harkiolaki, Peter J Sadler
Metal-Based Drugs
|
January 1, 1994
Probing the gold binding site in serum albumin
R E Sue, P J Sadler, A Tucker
Bioorganic & Medicinal Chemistry Letters
|
March 1, 2017
Recent developments in drug discovery against the protozoal parasites Cryptosporidium and Toxoplasma
Prinessa Chellan, Peter J Sadler, Kirkwood M Land
Therapeutic Drug Monitoring
|
July 23, 2020
Evaluation of Imatinib Concentrations in Samples Submitted for BCR-ABL1 or Imatinib Testing-Evidence to Support Therapeutic Drug Monitoring for Dose Optimization?
Laura Smy, Aaron J Sadler, Gwendolyn A McMillin
Page
of 68
Search research articles
Search
Showing results (101-110 of 675) with videos related to
Sort By:
Page
of 68
Journal of Medicinal Chemistry
|
September 24, 2015
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation
Isolda Romero-Canelón, Magdalena Mos, Peter J Sadler
Biochemical Society Transactions
|
October 1, 1980
31P nuclear-magnetic-resonance studies at 24 and 162 MHz of blood containing an anti-arthritic gold phosphine: relaxation via chemical-shift anisotropy
N A Malik, G Otiko, P J Sadler
FEBS Letters
|
October 15, 1978
113Cd nuclear magnetic resonance of metallothionein: non-equivalent CdS4 sites
P J Sadler, A Bakka, P J Beynon
Science (New York, N.Y.)
|
December 9, 1983
Equatorial undercurrent disappears during 1982-1983 el nino
E Firing, R Lukas, J Sadler, et al.
Journal of Applied Toxicology : JAT
|
November 24, 2006
Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells
D Pugazhendhi, A J Sadler, P D Darbre
Journal of Medicinal Chemistry
|
February 2, 2013
The contrasting activity of iodido versus chlorido ruthenium and osmium arene azo- and imino-pyridine anticancer complexes: control of cell selectivity, cross-resistance, p53 dependence, and apoptosis pathway
Isolda Romero-Canelón, Luca Salassa, Peter J Sadler
Chemical & Biomedical Imaging
|
March 27, 2026
A Correlative X‑ray Bioimaging Triad for Metals in Biomedical Research
Rafael C Marchi, Maria Harkiolaki, Peter J Sadler
Metal-Based Drugs
|
January 1, 1994
Probing the gold binding site in serum albumin
R E Sue, P J Sadler, A Tucker
Bioorganic & Medicinal Chemistry Letters
|
March 1, 2017
Recent developments in drug discovery against the protozoal parasites Cryptosporidium and Toxoplasma
Prinessa Chellan, Peter J Sadler, Kirkwood M Land
Therapeutic Drug Monitoring
|
July 23, 2020
Evaluation of Imatinib Concentrations in Samples Submitted for BCR-ABL1 or Imatinib Testing-Evidence to Support Therapeutic Drug Monitoring for Dose Optimization?
Laura Smy, Aaron J Sadler, Gwendolyn A McMillin
Page
of 68